K-numberK251958
Device nameVEINOPLUS Back
ApplicantDynapulse Medical
Product codeNUH
Device classClass II
Decision dateDec 23, 2025
DecisionSubstantially Equivalent
Regulation882.5890
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The VEINOPLUS Back is a non-invasive, battery-operated over-the-counter device that provides transcutaneous electrical nerve stimulation (TENS) for temporary pain relief. It consists of a handheld device with LCD screen, self-adhesive electrodes, connecting cable, and 9V battery. The device is designed specifically for pain associated with sore and aching muscles in the back (shoulder, middle back, or lumbar area) due to strain from exercise or normal household and work activities.

Technological characteristics

The subject device operates using the same TENS mechanism of action as the predicate with similar form factor (handheld unit, self-adhesive electrodes, battery power, user controls, and safety features). Key differences include: monophasic rectangular asymmetric waveform versus biphasic square; voltage regulation versus current regulation; maximum output voltage of 50±5V at 500Ω versus 96±20V; frequency range 1-120 Hz versus 1-150 Hz; and pulse width 25-240 microseconds versus 50-300 microseconds. Despite these differences, specifications remain within the predicate's range.

Test standards cited

Electrical safety and performance testing was completed in accordance with IEC 60601-1 (general requirements), IEC 60601-1-2 (electromagnetic compatibility), and IEC 60601-2-10 (particular standards for nerve stimulators).

Substantial equivalence argument

The subject device is substantially equivalent because it has the same intended use (TENS for temporary pain relief) and operates through the same mechanism of action as the predicate device. Although technical output specifications differ (waveform, frequency, voltage, pulse width), these differences are within the predicate's operating range and raise no different questions of safety or effectiveness. Testing demonstrated compliance with applicable safety and performance standards matching the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →